Malaysia: Malaysia realizes biotechnology potential


Timothy Siaw of Shearn Delamore & Co looks at how Malaysia intends to establish itself as a global leader in biotechnology

Malaysia has identified biotechnology as a key technology to drive and support its evolution into a knowledge-based economy. It is ready to learn from and emulate the best biotechnology R&D and industry practices and has set its sights on doubling the number of its biotechnology and biotechnology-related companies to 400 by 2010.

The National Biotechnology Policy

The National Biotechnology Policy was launched in 2005 to provide a comprehensive and coherent framework to guide the development of biotechnology in Malaysia. The Biotechnology Policy's main aims are to develop human resources to meet the industry's skills needs, and to nurture entrepreneurship and the development of niches in agriculture biotechnology, healthcare biotechnology, industrial biotechnology and bioinformatics.

The Biotechnology Policy provides a comprehensive framework for legal, regulatory and institutional changes. It also provides fiscal and financial incentives to foster innovation and investment in biotechnology in Malaysia.

The Malaysian Biotechnology Corporation The Malaysian Biotechnology Corporation...



Only subscribers have complete access to Managing IP Magazine, log in or subscribe now.

Alternatively take a free trial, giving you 48-hour access to Managing IP Magazine (some articles and surveys may be excluded).

Subscribe Now

This article is available to subscribers. Please click subscribe to read the rest of the article.

Subscribe

Take a free trial

Please take a free 48-hour trial to gain limited access. Some articles and surveys may be excluded.

Take a free trial


More from the Managing IP blog


June 2013

The Madrid Protocol comes of age

India’s accession means the Madrid Protocol now covers more than two-thirds of the world’s population. Is this the tipping-point for the international trade mark system, and what reforms are needed? Emma Barraclough, James Nurton and Alli Pyrah report



Most read articles

Poll

Following the US Apple v Samsung trial, do you think juries should play a role in patent cases?







Supplements